296 related articles for article (PubMed ID: 33289969)
1. Phosphoproteomics identifies microglial Siglec-F inflammatory response during neurodegeneration.
Morshed N; Ralvenius WT; Nott A; Watson LA; Rodriguez FH; Akay LA; Joughin BA; Pao PC; Penney J; LaRocque L; Mastroeni D; Tsai LH; White FM
Mol Syst Biol; 2020 Dec; 16(12):e9819. PubMed ID: 33289969
[TBL] [Abstract][Full Text] [Related]
2. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
3. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.
Gonzalez-Gil A; Porell RN; Fernandes SM; Maenpaa E; Li TA; Li T; Wong PC; Aoki K; Tiemeyer M; Yu ZJ; Orsburn BC; Bumpus NN; Matthews RT; Schnaar RL
J Biol Chem; 2022 Jun; 298(6):101960. PubMed ID: 35452678
[TBL] [Abstract][Full Text] [Related]
4. Siglec functions of microglia.
Linnartz-Gerlach B; Kopatz J; Neumann H
Glycobiology; 2014 Sep; 24(9):794-9. PubMed ID: 24833613
[TBL] [Abstract][Full Text] [Related]
5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
6. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of neurotoxicity by microglial human Siglec-11.
Wang Y; Neumann H
J Neurosci; 2010 Mar; 30(9):3482-8. PubMed ID: 20203208
[TBL] [Abstract][Full Text] [Related]
8. Microbial pathogens induce neurodegeneration in Alzheimer's disease mice: protection by microglial regulation.
Ganz T; Fainstein N; Elad A; Lachish M; Goldfarb S; Einstein O; Ben-Hur T
J Neuroinflammation; 2022 Jan; 19(1):5. PubMed ID: 34991645
[TBL] [Abstract][Full Text] [Related]
9. Roles of Siglecs in neurodegenerative diseases.
Siew JJ; Chern Y; Khoo KH; Angata T
Mol Aspects Med; 2023 Apr; 90():101141. PubMed ID: 36089405
[TBL] [Abstract][Full Text] [Related]
10. Ablation of Siglec-E augments brain inflammation and ischemic injury.
Li L; Chen Y; Sluter MN; Hou R; Hao J; Wu Y; Chen GY; Yu Y; Jiang J
J Neuroinflammation; 2022 Jul; 19(1):191. PubMed ID: 35858866
[TBL] [Abstract][Full Text] [Related]
11. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
[TBL] [Abstract][Full Text] [Related]
12. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
13. Polysialic acid and Siglec-E orchestrate negative feedback regulation of microglia activation.
Thiesler H; Beimdiek J; Hildebrandt H
Cell Mol Life Sci; 2021 Feb; 78(4):1637-1653. PubMed ID: 32725371
[TBL] [Abstract][Full Text] [Related]
14. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
15. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
Roy S; Mandal C
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
17. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.
Park J; Wetzel I; Marriott I; Dréau D; D'Avanzo C; Kim DY; Tanzi RE; Cho H
Nat Neurosci; 2018 Jul; 21(7):941-951. PubMed ID: 29950669
[TBL] [Abstract][Full Text] [Related]
18. Modulation of immune cell reactivity with
Delaveris CS; Chiu SH; Riley NM; Bertozzi CR
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431669
[TBL] [Abstract][Full Text] [Related]
19. Siglec-F Promotes IL-33-Induced Cytokine Release from Bone Marrow-Derived Eosinophils Independently of the ITIM and ITIM-like Motif Phosphorylation.
Westermann S; Dietschmann A; Doehler D; Castiglione K; Bochner BS; Voehringer D; Radtke D
J Immunol; 2022 Feb; 208(3):732-744. PubMed ID: 34996839
[TBL] [Abstract][Full Text] [Related]
20. Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.
Ghosh S; Geahlen RL
EBioMedicine; 2015 Nov; 2(11):1785-98. PubMed ID: 26870803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
